Your session is about to expire
← Back to Search
Nerve Block Timing for Shoulder Pain
N/A
Waitlist Available
Led By Marc Mecoli, MD
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
The subject is American Society of Anesthesiologists (ASA) patient classification I-II
The subject is age 10 years to 21 years (inclusive)
Must not have
Additional surgical procedures are being performed concurrently
The subject is ASA classification > II
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 minutes
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a procedure where pain medication is injected near neck nerves to manage pain after shoulder surgery. It targets healthy adolescents having shoulder reconstruction. The treatment works by numbing the nerves to block pain signals, helping reduce the need for other painkillers and speeding up recovery. This method has been found to be the most effective way to control pain after shoulder surgery.
Who is the study for?
This trial is for individuals aged 10-21 years with shoulder injuries requiring surgery, who are in good health (ASA I-II). They must consent to a nerve block and not have other surgeries at the same time. Excluded are those with severe health issues, pre-op sedation, allergies to local anesthetics, or conditions making them unsuitable for the study.
What is being tested?
The study compares different timings of administering a nerve block—either before or after shoulder surgery—to see which method better reduces post-operative pain. Participants will receive either a single shot or continuous catheter-delivered nerve blockade.
What are the potential side effects?
Potential side effects from the nerve blocks may include discomfort at injection site, weakness or numbness in the arm temporarily due to anesthesia effect on nerves, and less commonly allergic reactions to the medication used.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am in good or mild systemic disease condition according to ASA.
Select...
I am between 10 and 21 years old.
Select...
I have agreed to a specific type of anesthesia for my procedure, and a qualified clinician not involved in the study has obtained my consent.
Select...
I am scheduled for a one-sided shoulder surgery under general anesthesia without any other surgeries.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am having more than one surgery at the same time.
Select...
My health status is considered to be more than mildly compromised.
Select...
I will be given sedation before surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 60 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Pain Efficacy of Nerve Blockades
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Active Control
Group I: Preemptive Interscalene Block - Single ShotActive Control1 Intervention
Group II: Postoperative Interscalene Block - Single ShotActive Control1 Intervention
Group III: Preemptive Interscalene Block - CatheterActive Control1 Intervention
Group IV: Postoperative Interscalene Block - CatheterActive Control1 Intervention
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Nerve blocks work by injecting anesthetics or steroids near nerves to interrupt pain signals, providing targeted relief and reducing the need for systemic medications. This is particularly effective for post-operative pain management.
Other common treatments include opioids, which reduce pain perception by binding to receptors in the brain and spinal cord, and NSAIDs, which inhibit enzymes involved in inflammation and pain. Understanding these mechanisms is crucial for selecting the most appropriate and effective pain management strategy, minimizing side effects, and improving patient outcomes.
Find a Location
Who is running the clinical trial?
Children's Hospital Medical Center, CincinnatiLead Sponsor
839 Previous Clinical Trials
6,565,538 Total Patients Enrolled
19 Trials studying Pain
4,889 Patients Enrolled for Pain
Marc Mecoli, MDPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati
Jamie Furstein, CRNAPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati
1 Previous Clinical Trials
141 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 10 and 21 years old.I have agreed to a specific type of anesthesia for my procedure, and a qualified clinician not involved in the study has obtained my consent.I will be given sedation before surgery.I am in good or mild systemic disease condition according to ASA.You have allergies to local numbing medications.I am having more than one surgery at the same time.My health status is considered to be more than mildly compromised.I am scheduled for a one-sided shoulder surgery under general anesthesia without any other surgeries.I am either male or female.
Research Study Groups:
This trial has the following groups:- Group 1: Preemptive Interscalene Block - Single Shot
- Group 2: Postoperative Interscalene Block - Single Shot
- Group 3: Preemptive Interscalene Block - Catheter
- Group 4: Postoperative Interscalene Block - Catheter
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.